SS Innovations completes its first robotic cardiac surgery in Indonesia

SS Innovations International Inc. today said it has successfully performed its first-ever robotic cardiac surgery in Indonesia. The surgery was performed with the SSi Mantra system, which the company said demonstrates its commitment to making advanced robotic surgeries cost-effective and globally accessible.

The procedures included a bilateral, internal mammary artery coronary artery bypass graft (IMA CABG); an atrial septal defect (ASD) repair; and a beating heart totally endoscopic coronary artery bypass (TECAB). They were conducted at the Harapan Kita National Cardiac Hospital in Jakarta.

Dr. Sudhir Srivastava, the founder, chairman, and CEO of SS Innovations, performed the TECAB with support from his team from the company and the dedicated support staff of Harapan Kita led by Dr. Dudy Hanafy.

SSi Mantra offers modularity, visualization

Gurugram, India-based SS Innovations International offers the proprietary SSi Mantra Surgical Robotic System and SSi Mudra instrumentation. 

The SSi Mantra 3, which was released in July, is modular and allows surgeons to use three to five robotic arms. The system has an open-faced ergonomic Surgeon Command Centre, a 32-in. 3D 4K monitor, and a 23-in. 2D Touch panel monitor for all patient-related information display.

It also provides a virtual real-time image of the robotic Patient Side Arm Carts and can superimpose 3D models of diagnostic imaging. The system also supports telesurgery.

The Vision Cart gives the table-side team the same magnified 3D 4K view as the surgeon to provide better safety and efficiency, said SS Innovations. Meanwhile, the modular robotic arms provide flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations, it said.

The SSi Mantra includes more than 40 different types of robotic endo-surgical instruments that can be used for different specialties including cardiac surgery. SS Innovation said the learning curve for surgeons using this technology is short because of its ergonomic design and user-friendly features.

The SSi Mantra has been clinically validated in India in more than 80 different types of surgical procedures. In September, SS Innovations said more than 2,000 procedures have been conducted with its system. It also added Dr. Frederic Moll, founder of Intuitive Surgical, to its board.

The company said it has started the regulatory approval process in the U.S. and the European Union. It anticipates receiving Food and Drug Administration and CE Mark approval in the second half of 2025.

SS Innovations hopes to raise standard of cardiac care in Indonesia

SS Innovations assserted that launching the robotic cardiac surgery program at Harapan Kita represents the beginning of a new era in cardiac care in Indonesia. The island nation has a population of over 284 million and almost 3,000 hospitals. 

“We have been exploring the integration of robotic surgery in cardiovascular care at the Harapan Kita hospital and reviewed the globally available surgical robotic systems,” noted Dr. Iwan Dakota, the director and intervention cardiologist at NCVC Harapan Kita. “We found that the SSi Mantra is the only system supporting the full spectrum of robotic cardiac surgery, including TECAB.”

“Given its unique capabilities, we invited Dr. Srivastava’s team to demonstrate how the SSi Mantra performs as compared to other systems,” Dr. Dakota added. “The potential for implementing robotic surgery in our country is highly promising.”

Following the initial TECAB procedure, SS Innovations, in collaboration with Harapan Kita’s surgical team, performed seven to eight additional robotic-assisted procedures over the next several days. These included LIMA, BIMA, TECAB, and ASD Repair procedures. This collaboration aims to elevate the standard of cardiac care in the region.

“We are proud to partner with Harapan Kita National Cardiac Hospital to bring the most technologically advanced and cost-effective solutions to cardiac surgery to Indonesia,” stated Dr. Sudhir Srivastava, founder, chairman, and CEO of SS Innovations. “Reaching this milestone with SSi Mantra is a testament to our vision of transforming surgical practices, enhancing access, and driving the global adoption of cost-effective robotic surgery.”

“This collaboration addresses the critical need for safe, timely, and affordable cardiac care while offering patients less-invasive options and an improved quality of life,” he said.